Italia markets close in 6 hours 48 minutes

Harvard Bioscience, Inc. (HBIO)

NasdaqGM - NasdaqGM Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
3,5600-0,1300 (-3,52%)
Alla chiusura: 04:00PM EDT
3,5600 0,00 (0,00%)
Dopo ore: 04:20PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente3,6900
Aperto3,6950
Denaro3,4700 x 100
Lettera3,6800 x 100
Min-Max giorno3,4700 - 3,6950
Intervallo di 52 settimane3,4700 - 6,2900
Volume65.305
Media Volume88.308
Capitalizzazione154,58M
Beta (5 anni mensile)1,45
Rapporto PE (ttm)N/D
EPS (ttm)-0,0800
Prossima data utili06 mag 2024 - 21 mag 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A6,92
  • GlobeNewswire

    Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research

    Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI) Expands reach of unique, non-invasive wearable monitoring for pre-clinical research across North American and European markets HOLLISTON, Mass. and LYON, France, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) and Etisense announced today that they have entered into an agreement to offer DECRO®, Etisense’s non-invasive telemetry jacket and associated

  • GlobeNewswire

    Harvard Bioscience Announces Second Quarter 2023 Financial Results

    Q2 Revenues of $28.8 millionQ2 GAAP operating income $0.8 million, adjusted operating income $3.6 millionStrong H1 operating cash flow drove net debt reduction of $5.4 million HOLLISTON, Mass., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the second quarter ended June 30, 2023. Jim Green, Chairman and CEO said, “We are encouraged by the continuation of a strong start to the fiscal year, with growth from new produc

  • GlobeNewswire

    Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023

    HOLLISTON, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Sidoti August Virtual Investor Conference on August 16, 2023. Joining him will be Jennifer Cote, the company’s Chief Financial Officer and Treasurer. The presentation will begin at 11:30 a.m. ET on Wednesday, August 16th and can be accessed live here. The presentation will also be archived on the Investor